Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Elasticity Imaging Techniques | 17 | 2025 | 109 | 4.630 |
Why?
|
| Optometry | 7 | 2024 | 14 | 4.370 |
Why?
|
| Cornea | 15 | 2025 | 140 | 3.760 |
Why?
|
| Tomography, Optical Coherence | 16 | 2025 | 217 | 3.060 |
Why?
|
| Humans | 27 | 2025 | 5477 | 1.630 |
Why?
|
| Elasticity | 4 | 2021 | 35 | 1.420 |
Why?
|
| Riboflavin | 4 | 2018 | 25 | 1.240 |
Why?
|
| Glaucoma | 3 | 2021 | 40 | 1.150 |
Why?
|
| Intraocular Pressure | 6 | 2020 | 62 | 1.080 |
Why?
|
| Mentoring | 1 | 2024 | 13 | 0.870 |
Why?
|
| Optic Disk | 3 | 2015 | 59 | 0.840 |
Why?
|
| Biomechanical Phenomena | 9 | 2021 | 176 | 0.840 |
Why?
|
| Ultraviolet Rays | 4 | 2018 | 30 | 0.830 |
Why?
|
| Collagen | 4 | 2018 | 34 | 0.830 |
Why?
|
| Vision, Ocular | 5 | 2023 | 33 | 0.820 |
Why?
|
| Elastic Modulus | 7 | 2025 | 32 | 0.810 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2022 | 3 | 0.790 |
Why?
|
| Publications | 1 | 2022 | 2 | 0.770 |
Why?
|
| Animals | 16 | 2025 | 1817 | 0.770 |
Why?
|
| Research Report | 1 | 2022 | 1 | 0.740 |
Why?
|
| Orthokeratologic Procedures | 1 | 2022 | 9 | 0.740 |
Why?
|
| National Eye Institute (U.S.) | 1 | 2021 | 1 | 0.730 |
Why?
|
| Retina | 3 | 2012 | 130 | 0.720 |
Why?
|
| Biomedical Research | 1 | 2021 | 12 | 0.720 |
Why?
|
| Athletic Performance | 1 | 2021 | 3 | 0.710 |
Why?
|
| Sports | 1 | 2021 | 7 | 0.710 |
Why?
|
| Tonometry, Ocular | 5 | 2020 | 39 | 0.660 |
Why?
|
| Retinal Ganglion Cells | 4 | 2015 | 100 | 0.660 |
Why?
|
| Male | 11 | 2025 | 2765 | 0.660 |
Why?
|
| Rabbits | 6 | 2025 | 39 | 0.660 |
Why?
|
| Quality of Life | 1 | 2021 | 117 | 0.650 |
Why?
|
| Myopia | 1 | 2022 | 114 | 0.620 |
Why?
|
| Reproducibility of Results | 7 | 2021 | 350 | 0.610 |
Why?
|
| Photosensitizing Agents | 2 | 2018 | 9 | 0.600 |
Why?
|
| Choroid | 1 | 2016 | 25 | 0.500 |
Why?
|
| Aging | 2 | 2015 | 127 | 0.470 |
Why?
|
| Eye Diseases | 2 | 2017 | 17 | 0.460 |
Why?
|
| Ocular Physiological Phenomena | 1 | 2015 | 6 | 0.460 |
Why?
|
| Models, Statistical | 2 | 2012 | 70 | 0.450 |
Why?
|
| Phantoms, Imaging | 5 | 2025 | 85 | 0.450 |
Why?
|
| Circadian Rhythm | 1 | 2015 | 36 | 0.440 |
Why?
|
| Female | 7 | 2025 | 2811 | 0.430 |
Why?
|
| Patient Simulation | 1 | 2014 | 5 | 0.420 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 7 | 0.420 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 9 | 0.420 |
Why?
|
| Communication | 1 | 2014 | 33 | 0.410 |
Why?
|
| Biometry | 1 | 2013 | 32 | 0.410 |
Why?
|
| Educational Measurement | 1 | 2014 | 49 | 0.400 |
Why?
|
| Microscopy, Confocal | 3 | 2024 | 49 | 0.400 |
Why?
|
| Adult | 5 | 2025 | 1683 | 0.390 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 29 | 0.370 |
Why?
|
| Organ Size | 3 | 2018 | 31 | 0.370 |
Why?
|
| Lasers, Excimer | 1 | 2011 | 1 | 0.360 |
Why?
|
| Corneal Keratocytes | 1 | 2011 | 4 | 0.360 |
Why?
|
| Keratomileusis, Laser In Situ | 1 | 2011 | 4 | 0.360 |
Why?
|
| Algorithms | 4 | 2015 | 276 | 0.340 |
Why?
|
| Young Adult | 4 | 2025 | 850 | 0.340 |
Why?
|
| Cross-Linking Reagents | 4 | 2018 | 15 | 0.330 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 115 | 0.310 |
Why?
|
| Contact Lenses | 1 | 2010 | 71 | 0.300 |
Why?
|
| Pilot Projects | 3 | 2021 | 119 | 0.290 |
Why?
|
| Rats | 3 | 2015 | 251 | 0.290 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 3 | 2018 | 20 | 0.250 |
Why?
|
| Middle Aged | 3 | 2025 | 1098 | 0.240 |
Why?
|
| Mentors | 1 | 2024 | 7 | 0.220 |
Why?
|
| Periodicals as Topic | 1 | 2024 | 9 | 0.220 |
Why?
|
| Lens, Crystalline | 1 | 2024 | 34 | 0.220 |
Why?
|
| Models, Animal | 2 | 2015 | 25 | 0.200 |
Why?
|
| Rats, Inbred BN | 2 | 2013 | 3 | 0.200 |
Why?
|
| Bibliometrics | 1 | 2023 | 9 | 0.200 |
Why?
|
| Nerve Fibers | 2 | 2013 | 56 | 0.190 |
Why?
|
| Schools | 1 | 2022 | 39 | 0.190 |
Why?
|
| Universities | 1 | 2022 | 80 | 0.190 |
Why?
|
| Prescriptions | 1 | 2021 | 19 | 0.180 |
Why?
|
| Alabama | 1 | 2021 | 1 | 0.180 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2021 | 2 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2021 | 8 | 0.180 |
Why?
|
| Qualitative Research | 1 | 2022 | 47 | 0.180 |
Why?
|
| Eyeglasses | 1 | 2021 | 30 | 0.180 |
Why?
|
| Benchmarking | 1 | 2021 | 13 | 0.180 |
Why?
|
| Limbus Corneae | 1 | 2020 | 6 | 0.170 |
Why?
|
| Anterior Eye Segment | 1 | 2020 | 12 | 0.170 |
Why?
|
| Visual Perception | 1 | 2021 | 61 | 0.170 |
Why?
|
| Respiration | 1 | 2020 | 7 | 0.160 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 107 | 0.160 |
Why?
|
| Heart Rate | 1 | 2020 | 43 | 0.160 |
Why?
|
| Keratoconus | 2 | 2017 | 76 | 0.150 |
Why?
|
| United States | 1 | 2021 | 521 | 0.150 |
Why?
|
| Swine | 4 | 2024 | 51 | 0.140 |
Why?
|
| Osmolar Concentration | 1 | 2018 | 17 | 0.140 |
Why?
|
| Corneal Stroma | 1 | 2018 | 17 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2024 | 73 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 42 | 0.130 |
Why?
|
| Macula Lutea | 1 | 2016 | 17 | 0.130 |
Why?
|
| Rose Bengal | 1 | 2016 | 4 | 0.130 |
Why?
|
| Body Temperature | 1 | 2015 | 5 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 136 | 0.110 |
Why?
|
| Light | 1 | 2015 | 43 | 0.110 |
Why?
|
| Optical Imaging | 1 | 2014 | 18 | 0.110 |
Why?
|
| Risk Factors | 1 | 2015 | 184 | 0.110 |
Why?
|
| Video Recording | 1 | 2014 | 13 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2014 | 14 | 0.100 |
Why?
|
| Feedback | 1 | 2014 | 32 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 28 | 0.100 |
Why?
|
| Myxoma | 1 | 2012 | 1 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2012 | 1 | 0.100 |
Why?
|
| Ophthalmoscopy | 1 | 2012 | 10 | 0.100 |
Why?
|
| Physical Stimulation | 1 | 2012 | 17 | 0.100 |
Why?
|
| Retinal Vessels | 1 | 2012 | 16 | 0.100 |
Why?
|
| Ocular Hypertension | 1 | 2012 | 11 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 8 | 0.090 |
Why?
|
| Photography | 1 | 2012 | 8 | 0.090 |
Why?
|
| Surgical Flaps | 1 | 2011 | 2 | 0.090 |
Why?
|
| Calibration | 1 | 2011 | 9 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2011 | 21 | 0.090 |
Why?
|
| Cell Count | 1 | 2011 | 33 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2011 | 8 | 0.090 |
Why?
|
| Prospective Studies | 1 | 2011 | 132 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 8 | 0.090 |
Why?
|
| Retinal Diseases | 1 | 2011 | 13 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 35 | 0.080 |
Why?
|
| Transducers, Pressure | 1 | 2010 | 2 | 0.080 |
Why?
|
| Posture | 1 | 2010 | 33 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2010 | 40 | 0.080 |
Why?
|
| Time Factors | 1 | 2011 | 176 | 0.080 |
Why?
|
| Corneal Topography | 1 | 2009 | 37 | 0.070 |
Why?
|
| Pupil | 1 | 2009 | 45 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 250 | 0.070 |
Why?
|
| Fixation, Ocular | 1 | 2009 | 40 | 0.070 |
Why?
|
| Transducers | 1 | 2024 | 9 | 0.060 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2024 | 9 | 0.060 |
Why?
|
| Internet | 1 | 2021 | 35 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2020 | 8 | 0.040 |
Why?
|
| Finite Element Analysis | 1 | 2020 | 8 | 0.040 |
Why?
|
| Refraction, Ocular | 1 | 2021 | 127 | 0.040 |
Why?
|
| Sclera | 1 | 2020 | 57 | 0.040 |
Why?
|
| Models, Biological | 1 | 2020 | 131 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2016 | 10 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 32 | 0.030 |
Why?
|
| Viscosity | 1 | 2015 | 11 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2015 | 126 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 242 | 0.030 |
Why?
|
| Hardness Tests | 1 | 2012 | 1 | 0.020 |
Why?
|
| Air | 1 | 2012 | 2 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 10 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 15 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 73 | 0.020 |
Why?
|
| Mice | 1 | 2013 | 719 | 0.020 |
Why?
|
| Reference Standards | 1 | 2009 | 13 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 320 | 0.020 |
Why?
|
| Aged | 1 | 2009 | 859 | 0.010 |
Why?
|